Big Things Happening this Year for Retina Technologies at AAO 2022!

Retina Technologies has been invited to present our OcuVue™ Digital Vision Screening Platform in the New York Eye and Ear Infirmary of Mount Sinai booth at the AAO 2022 Conference in Chicago this year.

We are looking forward to this huge opportunity to meet and discuss with some of the most prestigious ophthalmologists in the world and presenting the results of the clinical trials for our VR Vision Testing Suite!

Our team will be presenting the results from our head-to-head clinical trial between VR and in-office functional tests at AAO 2022, the most selective ophthalmology conference in the world.  Margo Labkovich will highlight data from our accelerated perimetry, color blindness, Amsler grid, acuity, and contrast sensitivity tests.

Previous
Previous

Top Ophthalmology Journal, Translational Vision Science & Technology, Approves Publication of Our Virtual Reality (VR) Clinical Trial

Next
Next

American Academy of Ophthalmology Accepts VR Clinical Trial Presentation at AAO 2022!